Barry J. Goldstein - Articles and news items

Merck logo

FDA approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for type 2 diabetes

Industry news, News / 2 February 2012 / Merck

JANUMET XR can help many patients reach blood sugar goals…

MSD Logo

Fewer major adverse cardiovascular events in type 2 diabetes patients treated with JANUVIA ® (sitagliptin)

Industry news, News / 6 December 2011 / MSD

Data presented at the IDF 21st World Diabetes Congress…

Merck logo

FDA approves Merck’s JUVISYNC™ (sitagliptin and simvastatin) tablets

Industry news / 7 October 2011 / Merck

Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+